Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A trial to compare the efficacy and discontinuation of fingolimod and dimethyl fumarate in two large academic medical centers

Next Previous
Search
Trial Profile

A trial to compare the efficacy and discontinuation of fingolimod and dimethyl fumarate in two large academic medical centers

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Sep 2020

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Dimethyl fumarate (Primary) ; Fingolimod (Primary)
  • Indications Multiple sclerosis
  • Focus Adverse reactions

    • Most Recent Events

    • 12 Oct 2018 Results of 36-months follow-up, presented at the 34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis
    • 27 Apr 2018 24-months follow-up results assessing effectiveness and treatment discontinuation (n=1272) presented at the 70th Annual Meeting of the American Academy of Neurology
    • 28 Apr 2017 24-month follow up results (n=653) from Cleveland clinic presented at the 69th Annual Meeting of the American Academy of Neurology

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top